Press Releases 

 

Scientists identify antibodies that can neutralize omicron

| January 6, 2022 | 0 comments
An international team of scientists have identified antibodies that neutralize omicron and other SARS-CoV-2 variants. These antibodies target areas of the virus spike protein that remain essentially unchanged as the viruses mutate. By identifying the targets of these “broadly neutralizing” antibodies on the spike protein, it might be possible to design vaccines and antibody treatments
iPharmaTrials, News, Press Releases

Abbott receives FDA 510(K) clearance for the first rapid handheld blood test for concussions

| September 8, 2021 | 0 comments
-The test to help evaluate mild traumatic brain injury (TBI), commonly known as concussion, produces a result within 15 minutes after a plasma sample is inserted and will run on Abbott’s i-STAT™ Alinity™ handheld device – Having a blood test available could help eliminate wait time in the emergency room and could reduce the number
iPharmaTrials, Press Releases
Stoned drivers are a lot safer than drunk ones, new federal data shows

Stoned drivers are a lot safer than drunk ones, new federal data shows

| June 21, 2019 | 0 comments
A new study from the National Highway Traffic Safety Administration finds that drivers who use marijuana are at a significantly lower risk for a crash than drivers who use alcohol. And after adjusting for age, gender, race and alcohol use, drivers who tested positive for marijuana were no more likely to crash than who had
driving, medical marijuana
iPharmaTrials, News, Press Releases
Driver in Limousine Crash had Marijuana in System

Driver in Limousine Crash had Marijuana in System

| April 7, 2019 | 0 comments
Traces of anti-seizure medicine also were found in post-mortem tests SCHOHARIE — The driver of a Ford Excursion limousine that crashed in Schoharie last October, killing 20 people, had a “significant” amount of marijuana in his system at the time he died, according to two people with knowledge of the driver’s post-mortem toxicology report. The
anti-seizure medicine
iPharmaTrials, News, Press Releases
Health Effects of Cannabis and Cannabinoids

Health Effects of Cannabis and Cannabinoids

| January 14, 2019 | 0 comments
In the report The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research, an expert, ad hoc committee of the National Academies of Sciences, Engineering, and Medicine presents nearly 100 conclusions related to the health effects of cannabis and cannabinoid use. The committee developed standard language to categorize the
Cannabinoids, Cannabis
iPharmaTrials, News, Press Releases

Cannabinoid (CB1) Receptor Activation Inhibits Trigeminovascular Neurons

| July 14, 2018 | 0 comments
Simon Akerman, Philip R. Holland, and Peter J. Goadsby Headache Group, Institute of Neurology and the National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom Received April 29, 2006; accepted October 2, 2006 ABSTRACT Migraine is a common and disabling neurological disorder that involves activation or the perception of activation of the trigeminovascular
migraine
iPharmaTrials, Press Releases

Marijuana & Menstrual Cycles: An Unspoken Effect

| July 1, 2018 | 0 comments
Medical Marijuana is legal in 29 states with qualifying conditions ranging from Cancer, Epilepsy, Chronic Pain, IBS, MS, ALS, etc. Medical Marijuana is defined as cannabis used for medicinal sage, typically high in CBD or Cannabidiol a component of Marijuana that is effective in treating symptoms of the above listed conditions. As the program expands in NY since 2014, and enrolled patients has
CB1 Receptor, Hypothalamus, medical marijuana, Menstrual Cycles
iPharmaTrials, Press Releases
Antidepressants & Medical Marijuana: A Review

Antidepressants & Medical Marijuana: A Review

| June 9, 2018 | 0 comments
SSRIs SSRI’s or Selective Serotonin Reuptake Inhibitors are the most commonly prescribed antidepressant. SSRIs work by directly raising levels of serotonin via binding to SERT(5-HTT) allowing more serotonin to fit between neurons- while also increasing ITGB3 protein activity. In short- SSRIs increase serotonin easing the feeling depression and making you feel “happy” or good. SSRIs are typically metabolized
Antidepressants, medical marijuana
iPharmaTrials, Press Releases

*BREAKING NEWS* Image-Guided Surgery

| April 7, 2018 | 0 comments
What is image-guided surgery? The focus of On Target Laboratories is the discovery and development of small molecules that, when conjugated with fluorescent dyes, target and illuminate specific cancerous cells and other diseased tissue. This illumination may provide the surgeon with a clearer view of diseased tissue, creating another decision-making tool to benefit the patient.
iPharmaTrials, News, Press Releases

Cardiac Diffusion Tensor Imaging Parameters and Anthropometrics

| April 5, 2018 | 0 comments
Relationship between Cardiac Diffusion Tensor Imaging Parameters and Anthropometrics in Healthy Volunteers Background In vivo cardiac diffusion tensor imaging (cDTI) is uniquely capable of interrogating laminar myocardial dynamics non-invasively. A comprehensive dataset of quantative parameters and comparison with subject anthropometrics is required. Methods cDTI was performed at 3T with a diffusion weighted STEAM sequence. Data
iPharmaTrials, News, Press Releases

Resources

 

– Krishna’s Corner
– Krishna’s Blog
– Store

iPT Tweets

 

News

 

iPHARMA TRIALS

 

New York, USA
Telephone : 718-332-7878
rkrishna -AT- ipharmatrials.com
.. replace -AT- with @

United Kingdom
The Studio/East Batterlaw Farm
Seaham SR7 8RP

Corporation Registration Address:
330 Thornton Road Englewood NJ 07631